Medicine
Naloxone 0.4 mg/1 mL injection
Naloxone 0.4 mg/1 mL injection is a generic prescription medicine for intramuscular, intravenous, subcutaneous use, made by 18 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F). Protect from light. Store in carton…
Key facts
- Active ingredient (INN)
- Naloxone
- Brand
- Sold under the generic name
- Strength
- 0.4 mg/1 mL
- Dosage form
- Injection
- Route
- Intramuscular, intravenous, subcutaneous
- Packs
- 10 vials of 1 mL, 25 vials of 1 mL, 1 vial of 1 mL and 34 more
- Manufacturers
- Lifestar PharmaIndiaEugiaIndiaHealthFirstMedical Purchasing SolutionsHikma PharmaceuticalsA-S Medication SolutionsHealth FirstHenry ScheinHospiraNorthStar RxLLC
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F). Protect from light. Store in carton until contents have been used.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A06AH04 Naloxone
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 24 September 1986
- Identifiers
- RxCUI 1659929, 1191222, 1191250 +2DailyMed set ID d4c44b74-4e36-4b63-80eb-64ce99ccb39f, 8cc25cf1-008c-4808-baec-49f35a887fae, 2879294f-9af9-459e-e063-6394a90a0820 +26NDC 72603-590, 0641-6132, 70385-2033 +26Application ANDA218404, ANDA070299, ANDA207633 +7
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 70756-658-10 | Lifestar PharmaIndia | 29 February 2024 |
| 25 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 70756-658-25 | Lifestar PharmaIndia | 29 February 2024 |
| 1 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 70756-658-82 | Lifestar PharmaIndia | 29 February 2024 |
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 70756-850-10 | Lifestar PharmaIndia | 19 February 2026 |
| 25 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 70756-850-25 | Lifestar PharmaIndia | 19 February 2026 |
| 1 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 70756-850-82 | Lifestar PharmaIndia | 19 February 2026 |
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 55150-327-10 | EugiaIndia | 15 October 2019 |
| 25 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 55150-327-25 | EugiaIndia | 15 October 2019 |
| 25 vial in 1 carton / 1 mL in 1 vial | 0641-6132-25 | Hikma Pharmaceuticals | 24 September 1986 |
| 10 syringe in 1 carton / 1 mL in 1 syringe | 0641-6193-10 | Hikma Pharmaceuticals | 31 August 2025 |
| 25 vial in 1 carton / 1 mL in 1 vial | 0641-6260-25 | Hikma Pharmaceuticals | 1 March 2022 |
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 0409-1215-01 | Hospira | 12 July 2005 |
| 10 cartridge in 1 box / 1 mL in 1 cartridge | 0409-1782-69 | Hospira | 23 September 2005 |
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 36000-308-10 | Baxter Healthcare | 29 January 2021 |
| 24 syringe in 1 carton / 1 mL in 1 syringe | 76045-114-10 | Fresenius Kabi | 2 April 2024 |
| 1 mL in 1 vial | 51662-1242-1 | Health First | 18 August 2018 |
| 50 pouch in 1 case / 1 mL in 1 pouch | 51662-1242-3 | Health First | 15 June 2020 |
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 67457-292-02 | Mylan Institutional | 6 March 2014 |
| 1 vial in 1 package / 1 mL in 1 vial | 70385-2033-1 | Sina Health | 8 August 2017 |
| 10 vial in 1 carton / 1 mL in 1 vial | 70069-071-10 | Somerset Therapeutics | 8 August 2017 |
| 1 vial in 1 bag / 1 mL in 1 vial | 71872-7009-1 | Medical Purchasing Solutions | 6 May 2019 |
| 1 vial in 1 bag / 1 mL in 1 vial | 71872-7198-1 | Medical Purchasing Solutions | 29 January 2020 |
| 1 vial, single-dose in 1 bag / 1 mL in 1 vial, single-dose | 71872-7219-1 | Medical Purchasing Solutions | 11 September 2020 |
| 1 vial, single-dose in 1 bag / 1 mL in 1 vial, single-dose | 71872-7297-1 | Medical Purchasing Solutions | 16 November 2022 |
| 1 mL in 1 cartridge | 51662-1238-1 | HealthFirst | 3 September 2018 |
| 1 mL in 1 vial, single-dose | 51662-1544-1 | HealthFirst | 8 August 2021 |
| 10 pouch in 1 case / 1 vial, single-dose in 1 pouch / 1 mL in 1 vial, single-dose | 51662-1544-3 | HealthFirst | 22 April 2022 |
| 25 vial in 1 carton / 1 mL in 1 vial | 51662-1671-3 | HealthFirst | 24 September 1986 |
| 10 vial in 1 carton / 1 mL in 1 vial | 50090-5427-0 | A-S Medication Solutions | 8 January 2021 |
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 50090-6491-0 | A-S Medication Solutions | 19 May 2023 |
| 1 vial, single-dose in 1 bag / 1 mL in 1 vial, single-dose | 0404-9773-01 | Henry Schein | 28 October 2025 |
| 1 box in 1 bag / 1 cartridge in 1 box / 1 mL in 1 cartridge | 0404-9920-01 | Henry Schein | 13 January 2022 |
| 25 vial in 1 carton / 1 mL in 1 vial | 72572-450-25 | Civica | 11 November 2019 |
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 72603-590-10 | NorthStar RxLLC | 1 July 2024 |
| 25 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 72603-590-25 | NorthStar RxLLC | 1 July 2024 |
| 1 mL in 1 vial | 84549-071-10 | ProPharma Distribution | 27 August 2025 |
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 70518-4785-0 | Remedyrepack | 28 October 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Naloxone
Clinical summary
Naloxone is an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression. MedsAcross supplies Naloxone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about NaloxoneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Narcan prescribing information (Emergent Devices) · U.S. National Library of Medicine, DailyMed
- Nyxoid: European public assessment report (EPAR) · European Medicines Agency
Need Naloxone 0.4 mg/1 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.